ClinicalTrials.Veeva

Menu

Hypotension Prediction Index (HPI) in Patients Undergoing Robotic Assisted Radical Prostatectomy (HPI in RARP)

U

University of Foggia

Status

Completed

Conditions

Hypotension During Surgery

Treatments

Device: No Hypotension Prediction Index
Device: Hypotension Prediction Index

Study type

Interventional

Funder types

Other

Identifiers

NCT06535464
135/C.E. 2021

Details and patient eligibility

About

Robot assisted radical prostatectomy (RARP) is the leader in robotic treatment for prostate cancer. Goal-directed therapy (GDT) is the approach used, but HPI, a machine learning algorithm analysing arterial waveforms, might offer additional benefits. The aim of this prospective randomised study is to evaluate the cumulative amount of intraoperative arterial hypotension episodes in patients undergoing RARP managed by GDT protocol guided or not by HPI algorithm

Enrollment

80 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all consecutive patients undergoing RARP; American Society of Anaesthesiology (ASA) SCORE I-III

Exclusion criteria

  • Body Mass Index (BMI) of 18.5 to 35, uncontrolled arrhythmias, myocardial infarction or ischemic/hemorrhagic stroke in the last 6 months, III/IV stage Global Initiative for Chronic Obstructive Lung Disease, pulmonary fibrosis, contraindication to radial artery cannulation.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Sequential Assignment

Masking

Single Blind

80 participants in 2 patient groups

Goal-directed therapy guided by Hypotension Prediction Index algorithm
Active Comparator group
Treatment:
Device: Hypotension Prediction Index
Goal-directed therapy alone
Sham Comparator group
Treatment:
Device: No Hypotension Prediction Index

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems